Diaverum enters Greece, and plans expansion

Multinational dialysis giant Diaverum has entered the Greek market with the acquisition of six clinics. HBI hears the group has plans to consolidate more of the market and become the country’s best quality provider.

Fresenius Medical Care deconsolidation completed

The deconsolidation of multinational dialysis giant Fresenius Medical Care (FMC) from German health care conglomerate Fresenius Group has been completed. This means FMC is now a regular limited liability stock corporation; Fresenius Group still holds the largest minority stake (of 32.2%) in it but no longer has control over, nor unlimited liability in it.

Opportunity in Saudi dialysis

In a rapidly opening up Saudi market full of opportunities, how attractive is the dialysis sector? HBI hears the answer is less straightforward than you might expect.

Fresenius shares rocket to one year high

Germany-based healthcare conglomerate Fresenius SE is trading at its highest share price in over a year – and three high-profile investment banks predict things will get even better.

Fresenius half-year results get lukewarm reception

Investors had a mixed reaction to Fresenius’ half-year results, which saw the firm perform poorly on a group-level, but the core businesses highlighted by the restructuring plan perform well. The company did not confirm rumours of divestments.

Find Us